gms | German Medical Science

83. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

16.05. - 20.05.2012, Mainz

Artikel

Artikel empfehlen

Endoscopic CO2 laser treatment in supraglottic carcinoma – late oncological outcomes

Meeting Abstract

Suche in Medline nach

  • corresponding author Nicolae Constantin Balica - ENT Department Timisoara, Timisoara, Romania
  • Stan Cotulbea - ENT Department Timisoara, Timisoara, Romania
  • Alin Horia Marin - ENT Department Timisoara, Timisoara, Romania
  • Stelian Lupescu - ENT Department Timisoara, Timisoara, Romania
  • Andreea Steluta Ruja - Odontotherapy and Endodonty Department Timisoara, Timisoara, Romania

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. 83. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. Mainz, 16.-20.05.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. Doc12hnod198

doi: 10.3205/12hnod198, urn:nbn:de:0183-12hnod1987

Veröffentlicht: 4. April 2012

© 2012 Balica et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.

Gliederung

Text

Introduction: This study presents the indications, contraindications, limits and results of the treatment of laryngeal supraglottic carcinoma endoscopical with CO2 Laser and with classical open surgery.

Material and Methods: Between 1996 and 2010 were treated 52 patients. Between 1996 and 2005, in 27 patients (51,92%) (staged I and II, N0) we performed endoscopic CO2 Laser surgery with postoperative XRT on the cervical lymph nodes. In 8 cases (29,62%) we performed simple epiglottectomy, in 12 cases (44,44%) extended epiglottectomy and in 7 cases (25,92%) endoscopic HSL. 8 patients (29,62%) were staged I and 19 patients (70,37%) stage II. Between 1996 and 2010 we performed in 25 cases (48,07%) classic open HSL with bilateral selective neck dissection. 2 patients (8%) were in stage I, 12 patients (48%) in stage II and 11 patients (44%) in stage III (T2N1M0). Postoperative follow-up was between 12-48 month, average 36 month.

Results: We obtained the following oncological results in the group of endoscopic treatment: no evidence of disease (NED) – 22 cases [(81,48%) 8 patients in stage I and 14 patients in stage II] and local recurrences in 5 cases (18,51%, stage II). The functional results were good and very good in all cases. In the group of classic surgery the oncologic results were as follow: NED – 19 cases (76%) and local recurrences in 6 cases (24%) (2 patients (8%) in stage II and 4 patients (16%) in stage III T2N1M0). Total laryngectomy with or without neck dissection and adjuvant XRT was the recurrences therapeutic alternatives.

Conclusion: Endosocopic CO2 laser microsurgery appears to be an effective and safe alternative treatment for T1-T2N0 supraglottic carcinoma, with the same oncologic results and functional results superior than the other techniques.